Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur", or the "Company"), a Canadian public company developing cost-effective imaging contrast media, is pleased to announce the ...

With commercial sales now underway, Voyageur is focused on expanding distribution across Canada. This infrastructure is designed to scale alongside the Company’s Frances Creek Project ...

Voyageur’s approved barium contrast agents are optimized for a range of gastrointestinal imaging applications: ... a 100% owned, pharmaceutical grade barium sulfate resource.

Voyageur Pharmaceuticals ( ($TSE:VM) ) just unveiled an update. Voyageur Pharmaceuticals has entered the revenue stage with its first commercial ...

Chemical reaction occurring between an insoluble solid and a saltwater solution relates to an exchange of ionic components and is therefore referred to as ion-exchange reaction. In this paper, we used ...

This article is cited by 58 publications. Ricardo D. Sosa, Xi Geng, Jacinta C. Conrad, Michael A. Reynolds, Jeffrey D. Rimer. Suppressing Barium Sulfate Crystallization with Hydroxycitrate: A Dual ...

Meanwhile, Barium Selat group chief operating officer Navinkumar Maruthamuthu said: “This collaboration with Tex Cycle is a strategic step in aligning our upstream chemical and advanced material ...